Browse diseases

…an GBM orthotopic model using the GBM01 cell line.Methods Human GBM01 GFP-Luc cells were stereotaxically injected into the brain of N…

…(p50-IMC) slows the growth of syngeneic murine prostate cancer, pancreatic ductal carcinoma, neuroblastoma, and glioblastoma tumors, when given after a dos…

…nti-tumor immune responses, including potential applications in glioblastoma immunotherapy.…

…er 100,000 persons in the United States and a median age of 64, Glioblastoma is the most aggressive astrocytic brain malignancy, characteriz…

…y (in low grade tumours) can be considered; (3) for progressive PanNET post-alkylating drugs, avoid immediate sequential therapy of al…

…eptides by comprehensively profiling the immunopeptidome of two GBM cell lines GL261 and CT2A, and cross-presenting APCs. We catego…

…anker (KOTK) and KULeuven.References Schaff LR, Mellinghoff IK. Glioblastoma and Other primary brain malignancies in adults: a review. JAMA.…

…in-directed CAR T cells for specific and effective targeting of glioblastoma. Sci Transl Med. 2020 Mar 4;12(533)Ethics Approval The trial ( …

…hbehani GK, Riddell S, Cripe T, Cairo MS. Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vit…

…nhances the therapeutic efficacy of the PEPvIII vaccine against glioblastoma. In addition, this combination strategy also provides a promisi…

…cell cancers of the kidney, adenocarcinomas of the pancreas and glioblastoma. A subset of these protein differences could be rationalised by…

…-phase development to practice-changing trials, particularly in prostate cancer and neuroendocrine tumours. 51 In prostate cancer, the phase II…